Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer

Clinical trial NCT06050239 · UNKNOWN

Trial details

NCT number: NCT06050239
Sponsor: Nanjing First Hospital, Nanjing Medical University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2023-03-01
Primary completion: 2025-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.